Rena Therapeutics,Inc.
Booth No.: JHVSBooth: Japan Healthcare Venture Summit (JHVS)
Rena is commercializing HDO (Heteroduplex oligonucleotides).
Rena has licensed HDO to Takeda and Ionis, and each company is conducting drug discovery research. We do research DDS and found to be able to deliver HDO to the lung, kidney, etc for other organs besides the liver.
Rena will focus on joint research with pharmaceutical companies to discover nucleic acid drugs for target genes.
Rena has licensed HDO to Takeda and Ionis, and each company is conducting drug discovery research. We do research DDS and found to be able to deliver HDO to the lung, kidney, etc for other organs besides the liver.
Rena will focus on joint research with pharmaceutical companies to discover nucleic acid drugs for target genes.
Contact
*The following information is provided to enable inquiries to exhibitors.
Unauthorized use and reproduction for any other purpose is prohibited.
|
Rena Therapeutics,Inc. |
|
|
Business Category : CRO / CMO Division / Department : Business Development Country : Japan |
URL : https://www.renatherapeutics.com/ |
Register for the Business Matching System to check contact details of companies you are interested in and make appointments to meet with them during the exhibition!
What is the Business Matching System? ⇒ https://www.ics-expo.jp/biojapan/en/partnering.html
What is the Business Matching System? ⇒ https://www.ics-expo.jp/biojapan/en/partnering.html